Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Pursuant to Regulations ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences has informed BSE that its Board of Directors will meet on Thursday, February 12, 2026, at the company's registered office in Ahmedabad. The main item on the agenda is to consider and approve the unaudited standalone and consolidated financial results, along with the limited review report, for the quarter and nine months ended December 31, 2025 (Q3FY26 and 9MFY26). The company has also indicated that any other business may be taken up with the chair's permission. The trading window for insiders, including directors, KMPs, and designated persons, has already been closed and will remain shut until 48 hours after the results are officially declared.
This is a standard quarterly results intimation. Retail investors should watch for the Q3FY26 earnings announcement on or shortly after February 12, 2026, as the numbers could move the stock. No major corporate action (such as fundraising, dividend, or M&A) is indicated at this stage.